521 related articles for article (PubMed ID: 32392952)
1. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
[No Abstract] [Full Text] [Related]
2. Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China.
Han T; Liu H; Zhang H; Guo M; Zhang X; Duan Y; Sun F; Liu X; Zhang X; Zhang M; Liu F; Bao L; Xiao M; Liu W; Jiang R; Zheng J; Tian X; Gao Q; Zhang W; Guo W; Li L; Tong X
Front Pediatr; 2020; 8():182. PubMed ID: 32457854
[No Abstract] [Full Text] [Related]
3. [Risk factors for minimally invasive surfactant administration failure in preterm infants with respiratory distress syndrome].
Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FQ; Guo W; Li L; Xiao M; Liu WL; Jiang R
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):231-237. PubMed ID: 32204759
[TBL] [Abstract][Full Text] [Related]
4. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
Xu H; Xu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
[TBL] [Abstract][Full Text] [Related]
6. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants].
Lu D; Liu Y; Tong X
Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):187-93. PubMed ID: 26165015
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of surfactant administration via thin catheter in preterm infants with neonatal respiratory distress syndrome: A systematic review and meta-analysis.
Wu X; Feng Z; Kong J; Lai Y; Jia C; Xu Z; Wu F; Cui Q; Chen Y
Pediatr Pulmonol; 2021 Sep; 56(9):3013-3025. PubMed ID: 34215018
[TBL] [Abstract][Full Text] [Related]
9. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
[TBL] [Abstract][Full Text] [Related]
10. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
[TBL] [Abstract][Full Text] [Related]
11. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
13. [Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].
Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants
Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):273-279. PubMed ID: 33775045
[No Abstract] [Full Text] [Related]
14. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
15. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
Kaniewska U; Gulczyńska E
Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
[TBL] [Abstract][Full Text] [Related]
16. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
17. [The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn].
Liu S; Tong X
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):104-8. PubMed ID: 25876684
[TBL] [Abstract][Full Text] [Related]
18. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta BK; Saha AK; Mukherjee S; Saha B
Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
